Comparison alteration of blood glucose level in continue against discontinue usage metformin tablet in diabetic type II patients before surgery

Not Applicable

• Conditions: Diabet.; Non-insulin-dependent diabetes mellitus; E10, E14

• Registration Number: IRCT2014092210348N2
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

All diabetic type II patients between 25 to 100 years old who candidate for elective coronary bypass graft surgery.
Exclusion criteria: Emergency coronary bypass graft surgery; diabetic type I; heart faiure (EF < 35%); treating with dipyridamle; xanthine derivatives; amiodarone; cimitidine and positive inotrope drugs; renal dysfuction (BUN> 20mg/dl or Cr > 1.5 mg/dl); Off- pump coronary bypass grafsurgery and usage metformin more than 1000mg/day.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose level. Timepoint: Before and during and after surgery. Method of measurement: mg/dl.

Secondary Outcome Measures

Name	Time	Method
Blood cratenin level. Timepoint: Before and during and after surgery. Method of measurement: mg/dl.